Bausch Health Companies Inc (BHC) concluded trading on Thursday at a closing price of $5.51, with 4.16 million shares of worth about $22.93 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -34.87% during that period and on June 12, 2025 the price saw a gain of about 3.38%. Currently the company’s common shares owned by public are about 369.54M shares, out of which, 291.10M shares are available for trading.
Stock saw a price change of 19.01% in past 5 days and over the past one month there was a price change of 17.99%. Year-to-date (YTD), BHC shares are showing a performance of -31.64% which decreased to -12.82% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.96 but also hit the highest price of $9.85 during that period. The average intraday trading volume for Bausch Health Companies Inc shares is 2.12 million. The stock is currently trading 17.00% above its 20-day simple moving average (SMA20), while that difference is up 12.84% for SMA50 and it goes to -20.25% lower than SMA200.
Bausch Health Companies Inc (NYSE: BHC) currently have 369.54M outstanding shares and institutions hold larger chunk of about 56.74% of that.
The stock has a current market capitalization of $2.04B and its 3Y-monthly beta is at 0.29. It has posted earnings per share of -$0.11 in the same period. It has Quick Ratio of 0.97. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BHC, volatility over the week remained 1.23% while standing at 2.24% over the month.
Stock’s fiscal year EPS is expected to drop by -0.74% while it is estimated to increase by 10.00% in next year. EPS is likely to shrink at an annualized rate of 6.74% for next 5-years, compared to annual growth of 52.33% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on August 02, 2024 offering an Underweight rating for the stock and assigned a target price range of between $9 and $3 to it. Coverage by Raymond James stated Bausch Health Companies Inc (BHC) stock as a Mkt perform in their note to investors on July 10, 2024, suggesting a price target of $8 for the stock. Stock get a Hold rating from Truist on July 29, 2022.
